Entrada Therapeutics, Inc. (TRDA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 425.3M |
| Enterprise Value | 385.84M |
| P/E Ratio | -1.77 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 47.83 |
| Price/Book Ratio | 1.09 |
| Enterprise/Revenue | 43.18 |
| Enterprise/EBITDA | -1.5 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -28.95 |
| Operating Margin | -31.09 |
| Return On Assets | -0.5 |
| Return On Equity | -0.51 |
| Revenue | 25.42M |
| Revenue/Share | 0.14 |
| Gross Profit | 21.33M |
| EBITDA | -142.4M |
| Net Income | -143.75M |
| Diluted EPS | -3.47 |
| Total Cash | 254.86M |
| Total Cash/Share | 6.09 |
| Total Debt | 49.75M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 13.9 |
| Book Value Per Share | 6.47 |
| 52-Week Change | 0.43 |
| 52-Week High | 16.45 |
| 52-Week Low | 4.93 |
| Moving Average 50 Days | 9.48 |
| Moving Average 200 Days | 9.44 |
| Average Volume | 364,837 |
| Shares Outstanding | 38.82M |
| % Held by Institutions | 61.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |